Swarna Byri, MD
Nephrology · Modesto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 3
- Since medical school
- 23 years
- Graduated 2003
Offices
3 locations · Valley Nephrology Associates · 3 clinicians in this group
Looking this up.
Hospitals listed: 052723 · 552606 · 552752 · 552803 · 752526 · Adventist Health Sonora · Doctors Hospital of Manteca · Doctors Medical Center · Emanuel Medical Center · Memorial Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Byri’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A131314 · Current
Licensed to practise in California · since 2014 · expires 2027-07-31 · University of Health Sciences, Vijayawada, Guntur Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Naadi Manteca ASCAmbulatory Surgery Center · Manteca, CA5% owner since 2023 · accredited by AAAASFInitial AccreditationNo inspections published
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Nephrology
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health SonoraSonora, CAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Postoperative wound dehiscence rate: 3.5 (2.04 to 4.96) · 288 cases, Jul 2022 – Jun 2024Worse than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 1.3 (1 to 1.6) · 1,004 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.185, Oct 2024 – Sep 2025
- Doctors Hospital of MantecaManteca, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency departmentPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 55% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.165, Oct 2024 – Sep 2025
- Doctors Medical CenterModesto, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.36 (1.02 to 1.71), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.35 (0.81 to 1.9) · 6,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.281, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.326, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.183, Oct 2024 – Sep 2025
- Emanuel Medical CenterTurlock, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 58% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.231, Oct 2024 – Sep 2025
- Memorial Medical CenterModesto, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.093, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.085, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Sonora
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 1 better, 7 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative wound dehiscence rateComplications and deaths | 3.5 (2.04 to 4.96) · 288 cases | Worse | Jul 2022 – Jun 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.6) · 1,004 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.185 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.15 (0.14 to 2.16) · 582 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.5 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 182.91 (123.44 to 242.37) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9 · 125 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.7 · 236 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15 · 433 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12 · 72 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 1,364 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.39) · 3,671 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 3,602 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.24 to 5.59) · 803 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.24) · 310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.59 (0.98 to 4.2) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.97 (0 to 16.16) · 306 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.72 (1.85 to 9.58) · 277 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.06) · 2,750 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.614 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 105 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 209 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 12.6 · 119 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -23.8 · 255 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -13.4 · 455 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 381 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6 (4.3 to 8.1) · 328 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.7 (9.1 to 14.7) · 328 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 106 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.3) · 1,835 cases | No different | Jan 2022 – Dec 2024 |
What patients said (326 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Doctors Hospital of Manteca
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 4 the same, 2 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.165 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.09) · 230 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.49 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 30 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.5 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 700 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.33 (0.1 to 0.56) · 1,428 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,462 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.24 to 6.39) · 137 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.28 (0.57 to 4) · 130 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.23 to 3.28) · 58 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,152 cases | No different | Jul 2022 – Jun 2024 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 67.3 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 60 · 183 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.4 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 48 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.2 to 16.8) · 379 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 52 cases | No different | Jan 2024 – Dec 2024 |
What patients said (339 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 1 |
| Doctor communication | 1 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 68% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 77% |
| Doctors "always" explained things so they could understand | 62% |
| Doctors "always" listened carefully | 65% |
| Doctors "always" treated them with courtesy and respect | 76% |
| Patients who gave a rating of "9" or "10" (high) | 56% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 62% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 55% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Doctors Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 3 the same, 1 worse of 6 measures. Readmissions: 0 better, 5 the same, 3 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.36 (1.02 to 1.71) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.35 (0.81 to 1.9) · 6,296 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.281 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.326 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.183 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.31 to 2.23) · 1,396 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 183.31 (147.26 to 219.36) · 127 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 4.1 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.1 · 95 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 15.2 · 276 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.8 · 321 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 364 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.9 · 767 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 3,719 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 7,050 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 7,169 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.12 (2.19 to 6.06) · 1,622 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.6 (0 to 3.3) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.23 to 4.04) · 1,601 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 14.79 (5.73 to 23.85) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (0.75 to 9.23) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.9 · 67 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.484 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.582 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 424 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24 · 682 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 36.6 · 326 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 70.5 · 378 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 366 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 564 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 70 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.7 · 120 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.4) · 573 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.7) · 303 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,045 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 57% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 36% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Emanuel Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.231 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.94) · 622 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.46 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.82 (131.99 to 239.65) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.8 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 287 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12 · 365 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 443 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 1,680 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 4,151 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.53 (1.2 to 5.87) · 700 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.43) · 734 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.04) · 3,326 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 45 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.908 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.836 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.997 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 307 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 461 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -12.8 · 290 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.8 · 417 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 37.9 · 472 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.1 · 524 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.9 to 7.6) · 264 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.7 (7.4 to 12.8) · 264 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 40 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.5 to 19.3) · 257 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 289 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 14% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 79% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 58% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Memorial Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.093 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.085 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.41 to 2.2) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.75 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.77 (144.66 to 226.88) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.2 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.1 · 194 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.9 · 513 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 640 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 4,882 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.42) · 10,183 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 10,422 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.4 (1.58 to 5.23) · 2,596 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.92 (0.45 to 3.38) · 845 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.1 (1.78 to 4.42) · 2,439 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.71 (5.69 to 17.72) · 885 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.28 (3.75 to 10.81) · 829 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 563 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.2 (0 to 0.72) · 9,080 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 283 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.389 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.485 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.507 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 255 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 849 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 19.2 · 201 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8.4 · 584 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.6 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 895 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.3 to 6.9) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 273 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 108 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 341 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (10.2 to 16.1) · 2,334 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 717 cases | No different | Jan 2024 – Dec 2024 |
What patients said (655 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$356,672
Medicare paid this office $356,672 for 616 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 209 | $78,870 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 229 | $74,876 | $61 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 49 | $69,382 | $276 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 58 | $43,662 | $231 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 144 | $23,096 | $132 |
See all 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 209 | $78,870 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 229 | $74,876 | $61 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 49 | $69,382 | $276 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 58 | $43,662 | $231 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 144 | $23,096 | $132 |
| Return visit (30+ min) | 165 | $19,614 | $70 |
| Short return visit (20+ min) | 191 | $13,323 | $49 |
| Dialysis services, 1 physician visit per month (20 years or older) | 41 | $11,080 | $158 |
| New patient visit (45+ min) | 64 | $7,278 | $114 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 35 | $3,760 | $102 |
| Hemodialysis procedure with physician evaluation | 34 | $2,156 | $55 |
Who their Medicare patients are
616 Original Medicare patients in 2024. Average age 71 · Under 65 21% · 85 and older 11% · Women 46% · Also on Medicaid 69% · Health risk score 4.75. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 69% · Heart failure 49% · Coronary heart disease 45% · Atrial fibrillation 32% · COPD 28% · Depression 26% · Stroke 19% · Dementia 14% · Cancer 12%.
The office billed $922,567, Medicare allowed $463,553 and paid $356,672; for 3,526 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 616 | 3,526 | 71 | 4.75 | $922,567 | $356,672 |
| 2023 | 588 | 3,773 | 71 | 4.40 | $961,666 | $387,482 |
| 2022 | 651 | 2,985 | 71 | 4.22 | $862,655 | $330,185 |
| 2021 | 612 | 2,537 | 71 | 4.31 | $754,962 | $311,697 |
| 2020 | 442 | 2,442 | 70 | 5.17 | $645,384 | $242,409 |
| 2019 | 495 | 2,874 | 71 | 5.17 | $699,053 | $247,205 |
| 2018 | 415 | 2,349 | 71 | 4.81 | $521,163 | $190,379 |
| 2017 | 258 | 1,256 | 72 | 4.52 | $324,625 | $119,437 |
| 2016 | 187 | 626 | 73 | 4.34 | $166,822 | $61,710 |
| 2015 | 446 | 943 | 74 | 2.86 | $247,879 | $79,410 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 48 | $98,962 | $286 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 242 | $92,035 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 253 | $88,496 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 150 | $24,615 | $140 |
| Return visit (30+ min) | 176 | $22,498 | $71 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 31 | $15,407 | $241 |
| Short return visit (20+ min) | 163 | $12,979 | $49 |
| New patient visit (45+ min) | 56 | $7,091 | $127 |
| Dialysis services, 1 physician visit per month (20 years or older) | 22 | $5,930 | $160 |
| Hemodialysis procedure with physician evaluation | 45 | $3,842 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,552 | $104 |
2022: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 60 | $107,575 | $288 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 224 | $57,033 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 226 | $45,039 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 145 | $28,192 | $157 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 56 | $22,365 | $238 |
| Dialysis services, 1 physician visit per month (20 years or older) | 42 | $17,729 | $164 |
| Return visit (30+ min) | 177 | $17,659 | $63 |
| Short return visit (20+ min) | 185 | $10,649 | $41 |
| New patient visit (45+ min) | 65 | $6,695 | $103 |
| Hemodialysis procedure with physician evaluation | 36 | $3,174 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,921 | $108 |
2021: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 73 | $91,309 | $294 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 224 | $59,964 | $84 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 69 | $41,844 | $243 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 206 | $35,762 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 127 | $21,626 | $163 |
| Return visit (30+ min) | 135 | $21,253 | $102 |
| Short return visit (20+ min) | 109 | $9,320 | $68 |
| Dialysis services, 1 physician visit per month (20 years or older) | 26 | $9,123 | $169 |
| New patient visit (45+ min) | 72 | $8,955 | $124 |
| Hemodialysis procedure with physician evaluation | 41 | $3,338 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,092 | $110 |
2020: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 230 | $65,310 | $86 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 39 | $55,523 | $235 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 207 | $43,627 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 135 | $26,036 | $166 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 29 | $16,902 | $199 |
| Hemodialysis procedure with physician evaluation | 67 | $7,944 | $61 |
| Return visit (30+ min) | 57 | $7,240 | $86 |
| Short return visit (20+ min) | 75 | $5,781 | $54 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 42 | $5,082 | $113 |
| Dialysis services, 1 physician visit per month (20 years or older) | 13 | $3,236 | $154 |
| New patient visit (45+ min) | 25 | $3,038 | $122 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $968 | $81 |
| Emergency department visit with low level of medical decision making | 11 | $690 | $53 |
2019: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 246 | $65,292 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 270 | $61,054 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 201 | $36,163 | $156 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 32 | $34,811 | $222 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 25 | $12,697 | $184 |
| Hemodialysis procedure with physician evaluation | 93 | $10,068 | $57 |
| Return visit (30+ min) | 66 | $8,418 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 51 | $5,763 | $105 |
| Dialysis services, 1 physician visit per month (20 years or older) | 14 | $4,195 | $145 |
| Short return visit (20+ min) | 58 | $3,855 | $50 |
| New patient visit (45+ min) | 30 | $3,798 | $127 |
2018: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 216 | $54,268 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 200 | $46,562 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 159 | $32,031 | $162 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 13 | $14,390 | $228 |
| Hemodialysis procedure with physician evaluation | 86 | $9,969 | $58 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 15 | $8,510 | $189 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 64 | $7,643 | $109 |
| Return visit (30+ min) | 47 | $6,303 | $82 |
| Short return visit (20+ min) | 57 | $4,271 | $53 |
| New patient visit (30+ min) | 26 | $2,080 | $80 |
| New patient visit (45+ min) | 15 | $1,912 | $127 |
2017: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 157 | $47,307 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 122 | $25,480 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 77 | $14,120 | $58 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 12 | $4,034 | $192 |
| Return visit (30+ min) | 31 | $3,959 | $84 |
| Short return visit (20+ min) | 40 | $3,029 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,988 | $111 |
| Hemodialysis procedure with physician evaluation | 26 | $2,695 | $59 |
| New patient visit (45+ min) | 16 | $2,007 | $125 |
| Hemodialysis procedure with physician evaluation | 11 | $820 | $59 |
2016: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 114 | $27,216 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $14,273 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $4,850 | $58 |
| Return visit (30+ min) | 26 | $3,795 | $88 |
| New patient visit (60+ min) | 22 | $3,577 | $163 |
| Hemodialysis procedure with physician evaluation | 17 | $1,417 | $59 |
2015: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 277 | $46,015 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 68 | $11,203 | $165 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 86 | $7,235 | $59 |
| Hospital discharge day management, more than 30 minutes | 73 | $6,670 | $88 |
| Hospital discharge day management, 30 minutes or less | 29 | $1,726 | $60 |
| Hemodialysis procedure with physician evaluation | 15 | $1,356 | $59 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 26 | $1,108 | $32 |
Medicaid work
$238,272 in 2024
Medicaid paid $238,272 for 4,627 billed services this clinician did in 2024, up to 70 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 2,506 | $102,341 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 235 | $44,003 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 862 | $29,781 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 146 | $22,080 |
| Return visit (30+ min) | 330 | $13,794 |
| New patient visit (45+ min) | 105 | $8,349 |
| 1ST HOSP IP/OBS HIGH 75 | 138 | $8,095 |
| Short return visit (20+ min) | 277 | $7,932 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 14 | $1,370 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 14 | $528 |
| 2024 | 4,627 | 10 | 70 | $238,272 |
| 2023 | 5,562 | 9 | 70 | $254,205 |
| 2022 | 2,906 | 10 | 47 | $161,706 |
| 2021 | 1,857 | 8 | 42 | $118,006 |
| 2020 | 1,361 | 6 | 26 | $86,117 |
| 2019 | 1,102 | 6 | 29 | $55,618 |
| 2018 | 1,351 | 7 | 33 | $40,722 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 2,702 | $91,910 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 407 | $74,292 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 1,347 | $43,542 |
| Return visit (30+ min) | 448 | $16,255 |
| 1ST HOSP IP/OBS HIGH 75 | 246 | $14,364 |
| Short return visit (20+ min) | 320 | $7,062 |
| New patient visit (45+ min) | 50 | $3,585 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 14 | $2,079 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 28 | $1,116 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 325 | $61,618 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 993 | $33,847 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 765 | $30,693 |
| Return visit (30+ min) | 321 | $11,950 |
| 1ST HOSP IP/OBS HIGH 75 | 126 | $7,543 |
| Short return visit (20+ min) | 255 | $6,079 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 33 | $4,247 |
| New patient visit (45+ min) | 62 | $3,898 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month | 13 | $1,076 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 13 | $753 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 270 | $42,248 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 585 | $24,788 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 560 | $20,068 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 71 | $12,389 |
| Return visit (30+ min) | 200 | $8,290 |
| 1ST HOSP IP/OBS HIGH 75 | 58 | $4,831 |
| New patient visit (45+ min) | 48 | $3,865 |
| Short return visit (20+ min) | 65 | $1,527 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 233 | $46,483 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 494 | $17,832 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 420 | $14,426 |
| Return visit (30+ min) | 99 | $3,114 |
| 1ST HOSP IP/OBS HIGH 75 | 32 | $2,582 |
| Short return visit (20+ min) | 83 | $1,680 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 165 | $26,029 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 424 | $11,879 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 262 | $9,387 |
| Return visit (30+ min) | 177 | $5,852 |
| 1ST HOSP IP/OBS HIGH 75 | 30 | $1,610 |
| Short return visit (20+ min) | 44 | $862 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 720 | $17,955 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 468 | $14,507 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 25 | $2,699 |
| Short return visit (20+ min) | 61 | $1,891 |
| 1ST HOSP IP/OBS HIGH 75 | 29 | $1,460 |
| Return visit (30+ min) | 28 | $1,332 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 20 | $880 |
Drugs they prescribed that Part D paid
$627,151
Pharmacies billed $627,151 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,616 generic and fewer than 11 brand-name prescriptions · $627,151 in drug cost · 52 antibiotic prescriptions to 38 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tolvaptan | 14 | $153,896 | $10,993 |
| Farxiga | 158 | $105,036 | $665 |
| Veltassa | 95 | $89,647 | $944 |
| Jardiance | 80 | $53,450 | $668 |
| Lokelma | 86 | $50,067 | $582 |
See all 47 drugs
| Tolvaptan | 14 | $153,896 | $10,993 |
| Farxiga | 158 | $105,036 | $665 |
| Veltassa | 95 | $89,647 | $944 |
| Jardiance | 80 | $53,450 | $668 |
| Lokelma | 86 | $50,067 | $582 |
| Auryxia | 20 | $43,338 | $2,167 |
| Velphoro | 20 | $36,340 | $1,817 |
| Kerendia | 24 | $19,868 | $828 |
| Calcium Acetate | 113 | $8,891 | $79 |
| Dapagliflozin | 16 | $7,933 | $496 |
| Sevelamer Carbonate | 64 | $7,764 | $121 |
| Prosol | 33 | $5,735 | $174 |
| Tacrolimus | 18 | $5,195 | $289 |
| Mycophenolate Mofetil | 30 | $3,106 | $104 |
| Potassium Citrate Er | 35 | $2,822 | $81 |
| Hydralazine | 230 | $2,733 | $12 |
| Febuxostat | 29 | $1,808 | $62 |
| Furosemide | 569 | $1,711 | $3 |
| Calcitriol | 193 | $1,691 | $9 |
| Metolazone | 48 | $1,486 | $31 |
| Tamsulosin | 110 | $1,021 | $9 |
| Lisinopril | 157 | $953 | $6 |
| Gabapentin | 137 | $855 | $6 |
| Losartan | 119 | $686 | $6 |
| Bumetanide | 13 | $648 | $50 |
| Midodrine | 15 | $574 | $38 |
| Potassium Chloride | 38 | $574 | $15 |
| Amlodipine Besylate | 128 | $499 | $4 |
| Metoprolol | 38 | $374 | $10 |
| Allopurinol | 44 | $360 | $8 |
| Clonidine | 71 | $338 | $5 |
| Ondansetron | 24 | $335 | $14 |
| Metoprolol | 20 | $301 | $15 |
| Vitamin D2 | 32 | $274 | $9 |
| Fludrocortisone Acetate | 13 | $240 | $18 |
| Nitrofurantoin | 17 | $237 | $14 |
| Chlorthalidone | 21 | $166 | $8 |
| Prednisone | 41 | $152 | $4 |
| Atorvastatin | 32 | $151 | $5 |
| Hydrochlorothiazide | 14 | $149 | $11 |
| Olmesartan Medoxomil | 11 | $96 | $9 |
| Pantoprazole | 11 | $92 | $8 |
| Carvedilol | 30 | $89 | $3 |
| Spironolactone | 21 | $89 | $4 |
| Ciprofloxacin | 18 | $79 | $4 |
| Alprazolam | 24 | $76 | $3 |
| Glimepiride | 11 | $9 | $1 |
Year by year
| 2024 | 3,346 | 418 | None | None | $627,151 |
| 2023 | 3,422 | 425 | None | None | $703,406 |
| 2022 | 3,175 | 393 | 1% (16) | None | $530,533 |
| 2021 | 1,369 | 257 | None | 17% | $147,043 |
| 2020 | 1,000 | 131 | None | 23% | $83,527 |
| 2019 | 925 | 129 | None | 22% | $71,721 |
| 2018 | 569 | 92 | None | None | $33,080 |
| 2017 | 267 | 56 | None | 5% | $9,005 |
| 2016 | 97 | 28 | 0% (0) | 18% | $7,825 |
| 2015 | 265 | 63 | None | None | $25,591 |
| 2014 | 158 | 41 | 0% (0) | 16% | $7,368 |
| 2013 | 51 | 11 | 0% (0) | None | $1,029 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 46 drugs
| Farxiga | 318 | $230,598 | $725 |
| Veltassa | 74 | $71,583 | $967 |
| Auryxia | 18 | $38,909 | $2,162 |
| Jardiance | 52 | $38,602 | $742 |
| Velphoro | 19 | $36,120 | $1,901 |
| Lokelma | 65 | $35,695 | $549 |
| Kerendia | 38 | $32,671 | $860 |
| Sevelamer Carbonate | 43 | $31,038 | $722 |
| Calcium Acetate | 120 | $9,959 | $83 |
| Sirolimus | 11 | $7,646 | $695 |
| Prosol | 42 | $7,345 | $175 |
| Hydralazine | 223 | $4,471 | $20 |
| Furosemide | 531 | $3,401 | $6 |
| Febuxostat | 27 | $3,294 | $122 |
| Potassium Citrate Er | 11 | $2,687 | $244 |
| Metolazone | 40 | $2,402 | $60 |
| Midodrine | 29 | $2,282 | $79 |
| Bumetanide | 18 | $2,235 | $124 |
| Mycophenolate Mofetil | 17 | $2,184 | $128 |
| Calcitriol | 139 | $2,078 | $15 |
| Amlodipine Besylate | 175 | $1,998 | $11 |
| Losartan | 108 | $1,921 | $18 |
| Tamsulosin | 105 | $1,881 | $18 |
| Lisinopril | 193 | $1,742 | $9 |
| Gabapentin | 129 | $1,311 | $10 |
| Potassium Chloride | 42 | $1,287 | $31 |
| Tacrolimus | 11 | $1,218 | $111 |
| Atorvastatin | 37 | $821 | $22 |
| Clonidine | 52 | $754 | $14 |
| Allopurinol | 56 | $634 | $11 |
| Nitrofurantoin | 13 | $525 | $40 |
| Vitamin D2 | 54 | $515 | $10 |
| Carvedilol | 40 | $489 | $12 |
| Ondansetron | 21 | $387 | $18 |
| Metoprolol | 28 | $382 | $14 |
| Ciprofloxacin | 41 | $360 | $9 |
| Chlorthalidone | 30 | $358 | $12 |
| Loperamide | 11 | $308 | $28 |
| Pantoprazole | 16 | $283 | $18 |
| Prednisone | 30 | $149 | $5 |
| Glipizide | 12 | $148 | $12 |
| Escitalopram | 11 | $144 | $13 |
| Hydrochlorothiazide | 15 | $116 | $8 |
| Metoprolol | 11 | $93 | $8 |
| Irbesartan | 11 | $53 | $5 |
| Alprazolam | 12 | $35 | $3 |
2022: 47 drugs
| Farxiga | 334 | $214,462 | $642 |
| Lokelma | 91 | $48,741 | $536 |
| Sevelamer Carbonate | 49 | $37,658 | $769 |
| Velphoro | 15 | $32,249 | $2,150 |
| Veltassa | 33 | $29,259 | $887 |
| Kerendia | 24 | $17,888 | $745 |
| Clinisol | 90 | $17,604 | $196 |
| Tacrolimus | 27 | $11,630 | $431 |
| Prosol | 69 | $9,559 | $139 |
| Calcium Acetate | 84 | $8,616 | $103 |
| Procrit | 11 | $8,545 | $777 |
| Jardiance | 13 | $7,883 | $606 |
| Midodrine | 26 | $3,548 | $136 |
| Hydralazine | 165 | $2,503 | $15 |
| Calcitriol | 175 | $2,337 | $13 |
| Metolazone | 28 | $2,268 | $81 |
| Potassium Citrate Er | 23 | $2,251 | $98 |
| Furosemide | 420 | $2,176 | $5 |
| Potassium Chloride | 48 | $1,386 | $29 |
| Megestrol Acetate | 22 | $1,347 | $61 |
| Amlodipine Besylate | 156 | $1,230 | $8 |
| Clonidine | 11 | $1,229 | $112 |
| Losartan | 110 | $1,094 | $10 |
| Tamsulosin | 105 | $1,085 | $10 |
| Lisinopril | 142 | $948 | $7 |
| Gabapentin | 84 | $724 | $9 |
| Atorvastatin | 52 | $668 | $13 |
| Febuxostat | 18 | $563 | $31 |
| Nifedipine Er | 11 | $559 | $51 |
| Clonidine | 37 | $556 | $15 |
| Allopurinol | 35 | $450 | $13 |
| Chlorthalidone | 27 | $425 | $16 |
| Pregabalin | 11 | $407 | $37 |
| Omeprazole | 12 | $400 | $33 |
| Metoprolol | 29 | $362 | $12 |
| Carvedilol | 39 | $337 | $9 |
| Metoprolol | 15 | $289 | $19 |
| Escitalopram | 14 | $196 | $14 |
| Lactulose | 12 | $187 | $16 |
| Ciprofloxacin | 42 | $185 | $4 |
| Alprazolam | 50 | $143 | $3 |
| Citalopram Hbr | 14 | $135 | $10 |
| Vitamin D2 | 14 | $111 | $8 |
| Prednisone | 19 | $106 | $6 |
| Glipizide | 14 | $99 | $7 |
| Zolpidem | 13 | $56 | $4 |
| Olmesartan Medoxomil | 12 | $33 | $3 |
2021: 31 drugs
| Auryxia | 15 | $20,722 | $1,381 |
| Prosol | 56 | $15,089 | $269 |
| Sevelamer Carbonate | 47 | $14,502 | $309 |
| Lokelma | 18 | $13,631 | $757 |
| Farxiga | 20 | $12,298 | $615 |
| Clinisol | 56 | $8,763 | $156 |
| Calcium Acetate | 54 | $6,508 | $121 |
| Midodrine | 28 | $4,008 | $143 |
| Hydralazine | 115 | $2,053 | $18 |
| Metolazone | 12 | $1,632 | $136 |
| Potassium Citrate Er | 15 | $1,464 | $98 |
| Calcitriol | 72 | $1,454 | $20 |
| Furosemide | 161 | $1,110 | $7 |
| Potassium Chloride | 15 | $710 | $47 |
| Cyclobenzaprine | 15 | $664 | $44 |
| Amlodipine Besylate | 65 | $545 | $8 |
| Tamsulosin | 46 | $542 | $12 |
| Lisinopril | 97 | $533 | $5 |
| Chlorthalidone | 15 | $423 | $28 |
| Losartan | 39 | $260 | $7 |
| Gabapentin | 26 | $223 | $9 |
| Atorvastatin | 24 | $216 | $9 |
| Vitamin D2 | 15 | $196 | $13 |
| Carvedilol | 14 | $153 | $11 |
| Spironolactone | 16 | $120 | $7 |
| Alprazolam | 22 | $115 | $5 |
| Allopurinol | 16 | $106 | $7 |
| Metoprolol | 12 | $99 | $8 |
| Ciprofloxacin | 21 | $76 | $4 |
| Ropinirole | 13 | $62 | $5 |
| Olmesartan Medoxomil | 14 | $37 | $3 |
2020: 24 drugs
| Prosol | 50 | $13,308 | $266 |
| Sevelamer Carbonate | 39 | $9,777 | $251 |
| Lokelma | 11 | $8,360 | $760 |
| Intralipid | 31 | $6,859 | $221 |
| Clinolipid | 27 | $6,322 | $234 |
| Calcium Acetate | 38 | $4,236 | $111 |
| Clinisol | 17 | $2,301 | $135 |
| Midodrine | 18 | $1,937 | $108 |
| Hydralazine | 94 | $1,397 | $15 |
| Calcitriol | 66 | $1,062 | $16 |
| Cyclobenzaprine | 26 | $884 | $34 |
| Furosemide | 102 | $808 | $8 |
| Tamsulosin | 38 | $281 | $7 |
| Losartan | 35 | $280 | $8 |
| Lisinopril | 56 | $258 | $5 |
| Minoxidil | 13 | $239 | $18 |
| Atorvastatin | 22 | $231 | $11 |
| Spironolactone | 15 | $224 | $15 |
| Amlodipine Besylate | 47 | $190 | $4 |
| Glipizide Er | 11 | $141 | $13 |
| Gabapentin | 23 | $120 | $5 |
| Alprazolam | 16 | $102 | $6 |
| Metoprolol | 12 | $85 | $7 |
| Ciprofloxacin | 12 | $59 | $5 |
2019: 26 drugs
| Intralipid | 98 | $24,655 | $252 |
| Sevelamer Carbonate | 18 | $9,190 | $511 |
| Prosol | 22 | $3,258 | $148 |
| Demeclocycline | 12 | $3,109 | $259 |
| Midodrine | 27 | $2,139 | $79 |
| Hydralazine | 67 | $2,034 | $30 |
| Calcium Acetate | 18 | $1,172 | $65 |
| Calcitriol | 36 | $768 | $21 |
| Cyclobenzaprine | 22 | $683 | $31 |
| Furosemide | 82 | $656 | $8 |
| Gabapentin | 41 | $438 | $11 |
| Bumetanide | 16 | $404 | $25 |
| Lisinopril | 68 | $318 | $5 |
| Metoprolol | 22 | $295 | $13 |
| Carvedilol | 27 | $280 | $10 |
| Amlodipine Besylate | 36 | $265 | $7 |
| Ciprofloxacin | 23 | $218 | $9 |
| Doxazosin Mesylate | 13 | $212 | $16 |
| Tamsulosin | 25 | $198 | $8 |
| Losartan | 22 | $193 | $9 |
| Glipizide Er | 14 | $161 | $11 |
| Clonidine | 14 | $149 | $11 |
| Isosorbide Mononitrate Er | 11 | $148 | $13 |
| Spironolactone | 19 | $142 | $7 |
| Alprazolam | 13 | $98 | $8 |
| Hydrochlorothiazide | 20 | $73 | $4 |
2018: 15 drugs
| Intralipid | 38 | $8,896 | $234 |
| Sevelamer Carbonate | 11 | $8,576 | $780 |
| Prosol | 17 | $2,767 | $163 |
| Calcitriol | 32 | $878 | $27 |
| Calcium Acetate | 13 | $874 | $67 |
| Midodrine | 19 | $843 | $44 |
| Hydralazine | 30 | $325 | $11 |
| Lisinopril | 80 | $324 | $4 |
| Furosemide | 42 | $260 | $6 |
| Tamsulosin | 28 | $224 | $8 |
| Amlodipine Besylate | 41 | $191 | $5 |
| Ciprofloxacin | 15 | $161 | $11 |
| Carvedilol | 17 | $109 | $6 |
| Losartan | 18 | $108 | $6 |
| Metoprolol | 23 | $101 | $4 |
2017: 8 drugs
| Nifedipine Er | 13 | $662 | $51 |
| Hydralazine | 17 | $169 | $10 |
| Lisinopril | 27 | $156 | $6 |
| Amlodipine Besylate | 30 | $127 | $4 |
| Calcitriol | 16 | $117 | $7 |
| Losartan | 17 | $98 | $6 |
| Furosemide | 15 | $40 | $3 |
| Carvedilol | 13 | $25 | $2 |
2016: 1 drug
| Losartan | 12 | $49 | $4 |
2015: 8 drugs
| Renvela | 12 | $17,670 | $1,472 |
| Nifedipine Er | 11 | $699 | $64 |
| Calcium Acetate | 14 | $684 | $49 |
| Hydralazine | 11 | $320 | $29 |
| Furosemide | 24 | $109 | $5 |
| Losartan | 21 | $96 | $5 |
| Sulfamethoxazole-Trimethoprim | 12 | $88 | $7 |
| Carvedilol | 13 | $81 | $6 |
2014: 4 drugs
| Calcium Acetate | 12 | $1,440 | $120 |
| Hydralazine | 15 | $326 | $22 |
| Losartan | 14 | $78 | $6 |
| Furosemide | 16 | $63 | $4 |
2013: 1 drug
| Losartan | 14 | $294 | $21 |
Money from drug and device companies
$235 in 2024
| 2024 | 3 | 4 | None | $235 |
| 2023 | 2 | 3 | None | $58 |
| 2022 | 10 | 33 | None | $555 |
| 2021 | 6 | 11 | None | $212 |
| 2019 | 1 | 1 | None | $61 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Baxter Healthcare | None | $113 | 1 payment
|
| Bard Peripheral Vascular | Fluency Endovascular Stent Graft | $95 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $27 | 2 payments
|
See all 4 published payments
| Bard Peripheral Vascular | Meals · 2024-12-30 | Fluency Endovascular Stent Graft | $95 |
| Baxter Healthcare | Meals · 2024-12-04 | None | $113 |
| AstraZeneca Pharmaceuticals LP | Meals · 2024-06-29 | Farxiga | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2024-06-01 | Farxiga | $13 |
See earlier years (2023, 2022, 2021, 2019)
2023: $58
| Horizon Therapeutics plc | Krystexxa | $43 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $16 | 1 payment
|
2022: $555
| Mallinckrodt Hospital Products | Acthar | $120 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $120 | 4 payments
|
| Baxter Healthcare | Renal - Pd | $87 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $47 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $43 | 2 payments
|
| Fresenius USA Marketing | Velphoro | $33 | 2 payments
|
| GlaxoSmithKline | Benlysta | $28 | 1 payment
|
| Aurinia Pharma U.S. | Lupkynis | $27 | 1 payment
|
| Vifor Pharma | Veltassa | $25 | 2 payments
|
| Akebia Therapeutics | Auryxia | $25 | 1 payment
|
2021: $212
| Mallinckrodt Hospital Products | Acthar | $99 | 5 payments
|
| GlaxoSmithKline | Benlysta | $40 | 2 payments
|
| Horizon Therapeutics plc | Krystexxa | $24 | 1 payment
|
| Vifor Pharma | Veltassa | $19 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $17 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $14 | 1 payment
|
2019: $61
| Otsuka America Pharmaceutical | Samsca | $61 | 1 payment
|
Professional record
- NPI
- 1871731414
- Licence
- AZ R70453, CA A131314California A131314: Current · expires 2027-07-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Hospitalist (208M00000X)
- Mailing address
- Po Box 144, Manteca, CA, 95336
- NPI first listed
- 2009-02-04
- NPI last updated
- 2025-05-06
- NPI record certified
- 2025-05-06
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3141 Pellaro Ct, Pleasanton, CA, 94566